Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma
长期生存率和生物标志物分析评估新辅助联合辅助治疗瑞拉利单抗(抗LAG3)和纳武利尤单抗(抗PD-1)在可切除黑色素瘤患者中的疗效
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-00494
Burton, Elizabeth M; Milton, Denái R; Tetzlaff, Michael T; Wani, Khalida; Ross, Merrick I; Postow, Michael A; Lazcano, Rossana; Glitza, Isabella C; Wong, Michael K; Patel, Sapna P; Diab, Adi; Gershenwald, Jeffrey E; McQuade, Jennifer L; Betof Warner, Allison; Prieto, Victor G; Lee, Jeffrey E; Goepfert, Ryan P; Fisher, Sarah B; Song, Addison; Malke, Jared; Simon, Julie M; Ariyan, Charlotte; Torres-Cabala, Carlos A; Davies, Michael A; Lazar, Alexander; Wargo, Jennifer A; Tawbi, Hussein A; Amaria, Rodabe N